PT Medikaloka Hermina Tbk (IDX:HEAL)

Market Cap	13.17T -31.1%
Revenue (ttm)	7.22T +7.8%
Net Income	406.08B -13.5%
EPS	26.86 -14.2%
Shares Out	15.32B
PE Ratio	32.02
Forward PE	25.49
Dividend	10.50 (1.24%)
Ex-Dividend Date	May 5, 2026

Volume	6,037,000
Open	890.00
Previous Close	850.00
Day's Range	830.00 - 890.00
52-Week Range	760.00 - 1,775.00
Beta	-0.21
Analysts	Buy
Price Target	1,552.27 (+80.5%)
Earnings Date	Jul 31, 2026

About PT Medikaloka Hermina Tbk

PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, plastic and reconstructive surgery, neurosurgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, primary care family medicine, nuclear medicine and molecular theranostics, psychiatry, andrology, dietetics, lactation counseling, and dermatology and venereology. It also...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1985
• Employees: 18,785
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: HEAL

Financial Performance

In 2025, PT Medikaloka Hermina Tbk's revenue was 7.13 trillion, an increase of 6.20% compared to the previous year's 6.72 trillion. Earnings were 429.55 billion, a decrease of -19.85%.

Analyst Summary

According to 11 analysts, the average rating for HEAL stock is "Buy." The 12-month stock price target is Rp 1,552, which is an increase of 80.50% from the latest price.

Price Target

Rp 1,552

(80.50% upside)

Analyst Consensus: Buy